Bortezomib Consolidation after Frontline Auto-Allogeneic Transplant: Low Toxicity and Frequent Immunophenotypic Complete Responses in High-Risk or Young Myeloma Patients

Authors :: Émilie Lemieux-Blanchard
Rafik Terra
Richard Leblanc
Imran Ahmad
Léa Bernard
Jean-Sébastien Delisle
Sandra Cohen
Thomas Kiss
Michael Sebag
Guy Sauvageau
Nadia M. Bambace
Denis-Claude Roy
Séverine Landais
Silvy Lachance
Jean Roy
Source :: Biology of Blood and Marrow Transplantation. 24:S250-S251
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
Consolidation (soil)
Low toxicity
business.industry
Bortezomib
Internal medicine
medicine
Hematology
business
medicine.drug

Full Text Access

Tools